Advocacy intelligence hub — real-time data for patient organizations
Aptamer Sciences, Inc. — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Matthew Maurer, MD
Myeloid Therapeutics
Zhenfeng Zhang, MD,PhD
Second Affiliated Hospital of Guangzhou Medical University
Michael Ortiz, MD
Memorial Sloan Kettering Cancer Center
Manon ALLAIRE, Dr
Assistance Publique - Hôpitaux de Paris
Patricia Pascual
Centro de Investigación Biomédica en Red de Enfermedades Raras
Pedro Arias
Centro de Investigación Biomédica en Red de Enfermedades Raras
📍 LOS ANGELES, CA